CAS: 3973-08-8; Thiazole-4-Carboxylic Acid

该化合物是一种杂交有机化合物,其特点是存在硫磺和氮原子的五人环.该化合物在硫酸环的4个位置上有一个碳酸功能组(-COOH),有助于其酸性.Thiazole-4-carboxylic酸通常是一种白到白的晶体固体,在水和酒精等极地溶剂中溶解,这在碳酸中很常见.由于硫酸环和碳酸组的存在,该化合物呈现出各种化学再活动,使其在有机合成中有用,并成为制药和农用化学化学的建筑块.此外,硫酸衍生物因其生物活动而闻名,包括抗微生物和抗硫酸特性.在处理和使用时,应参考安全数据,如任何化学物质.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

1,2,3,4-tetrahydroisoquinoline thiazole-4,5-dicarboxylic acid ethyl 2-bromothiazole-4-carboxylate 2-propionyl-thiazole-4-carboxylic acid 4-thiazolecarboxylate methyl ester 1,3-thiazole-4-carbonyl chloride N-phenylthiazole-4-carboxamide thiazole-4-carbothioic acid anilide

合成工艺路线路线简述

  • 合成目标产物 4-Thiazolecarboxylic Acid 主要起始原料 4-Methylthiazole
  • (文献来源)合成步骤主要原料 4-Methylthiazole

海关参考信息

专利信息


专利号:WO-0110798-A1
优先权日:1999-08-04
标题 :Solid phase synthesis of oxa- and thiazoles
发明人:BUNIN BARRY A; TUSHUP STEVEN P
权利人:CHEMRX ADVANCED TECHNOLOGIES I; BUNIN BARRY A; TUSHUP STEVEN P
摘要:Thia- and oxazole-4-carboxylic acid derivatives are prepared by solid phase synthesis, using intermediates of formula (α) where SS is a solid support and n is 0 or 1.

专利号:WO-2024129887-A1
优先权日:2022-12-13
标题:Biobased synthesis of glucodiamine
发明人:MILLET AGUSTIN; WOELK HANS-JOERG; LEE TONI M; CHAKRABARTI GAURAB; HUNT SEAN
权利人:SOLUGEN INC
摘要:A method of preparing glucodiamine, comprising contacting glucose with an enzyme oxidation catalyst under conditions suitable for the formation of glucodialdose; contacting glucodialdose with a nitrogen-containing compound under conditions suitable for the formation of glucodioxime; and reducing glucodioxime under conditions suitable for the formation of glucodiamine. A method of preparing glucodiamine, comprising contacting glucodioxime with a dehydration catalyst under conditions suitable for the formation of glucodinitrile; and reducing glucodinitrile under conditions suitable for the formation of glucodiamine. A chemoenzymatic method of producing a bio-based amide platform chemical, comprising: contacting glucose with a biocatalyst under conditions suitable for the formation of glucodialdose; contacting glucodialdose with a base under conditions suitable for the formation of glucodioxime; and contacting glucodioxime with a hydrogenation catalyst in the presence of hydrogen under conditions suitable for formation of glucodiamine.

专利号:WO-0127095-A1
优先权日:1999-10-14
标 题:Method for producing 2-(n-boc-aminomethyl)-thiazol-4-carboxylic acid
发明人:BUSCHMANN ERNST; PFEIFFER THOMAS
权利人:BASF AG; BUSCHMANN ERNST; PFEIFFER THOMAS
摘要:The synthesis of dolastatin 3, which inhibits cell growth, requires a 2-aminomethyl-thiazol-4-carboxylic acid that is protected on the amino group as a building block. The invention provides a synthesis for producing this compound with a high degree of purity and a high yield so that it is also feasible on an industrial scale. To this end, a glycine thioamide with a protective group on the amino group is reacted preferably with 3-brom-2-oxo-propionic acid in the presence of at least one tertiary amine.

专利号:US-2018147294-A1
优先权日:2013-06-06
标 题:Antibody-drug conjugates, compositions and methods of use
发明人:JACKSON DAVID Y; HA EDWARD; PROBST GARY D
权利人:JACKSON DAVID Y; HA EDWARD; PROBST GARY D
摘要:Antibody-cytotoxin antibody-drug conjugates and related compounds, such as linker-cytotoxin conjugates and the linkers used to make them, tubulysin analogs, and intermediates in their synthesis; compositions; and methods, including methods of treating cancers.

专利号:US-10308595-B2
优先权日:2013-02-15
标 题:Albicidin derivatives, their use and synthesis
发明人:SUESSMUTH RODERICH; KRETZ JULIAN; SCHUBERT VIVIEN; PESIC ALEXANDER; HUEGELLAND MANUELA; ROYER MONIQUE; COCIANCICH STEPHANE; ROTT PHILIPPE; KERWAT DENNIS; GRAETZ STEFAN
权利人:UNIV BERLIN TECH
摘要:Antibiotically active compounds characterized by general formula (I), wherein X1, BB, BC, BD, BE and X2 are building blocks with D1, D2, D3, D4 or D5 being linkers which include carbon, sulphur, nitrogen, phosphor and/or oxygen atoms and which are covalently connecting the moities BA and BB, BB and BC, BC and BD, BD and BE and BE and BF, respectively, and wherein in particular the building block BC comprises an amino acid derivative. The compounds for use in a method of treatment of diseases, in particular for use in a method of treatment of bacterial infections are also disclosed.

专利号:EP-4634396-A1
优先权日:2022-12-13
标 题:Biobased synthesis of glucodiamine
上海鼎雅药物化学科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.dingyapharm-chem.com
企业联系电话:021-51320687👤
📞上海鼎雅药物化学科技有限公司 ⚠️参考联系方式
联系人:阮晓娜
电话:021-51320687
手机:18121218903
传真:021-51371369
邮箱:info@dingyapharm-chem.com,sales@dingyapharm-chem.com
通信地址: 上海张江哈雷路1043号304室
邮编: 201203
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:上海张江哈雷路1043号304室
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
苏州楚凯药业有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.chukaipharma.com
电话: 0512-88812066👤
📞苏州楚凯药业有限公司 ⚠️参考联系方式

销售电话:0512-88812066
邮箱:info@chukaipharma.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
上海邦成化工有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.bangchengchem.com
企业联系电话:021-69106990;69106980;13701823733👤
📞上海邦成化工有限公司 ⚠️参考联系方式
联系人:卢小姐
电话:021-69106990;69106980;13701823733
手机:13701823733
传真:QQ:89190072
邮箱:13701823733@163.com
通信地址: 上海市青浦区重固镇赵重公路2278号5号楼3层C57座
邮编: 201803
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:上海市青浦区重固镇赵重公路2278号5号楼3层C57座
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


摘要:S55 | ZINC15PHARMA | Pharmaceuticals from ZINC15 | DOI:10.5281/zenodo.3247749
摘要:Kleemann, A.; Engel, J.; Kutscher, B.; Reichert, D., Pharmaceutical Substances[Online], Thieme: Stuttgart, (2003).
摘要:Kikelj, D.; Urleb, U., Science of Synthesis, (2002) 11, 770.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知